State Street SPDR標普製藥ETF XPH 深 滬
等待開盤 02-12 09:30:00 美东时间
57.3099
-0.350
-0.61%
華盛通- 最 高57.3099
- 今 開56.80
- 成交量 4.03万股
- 最 低 56.69
- 昨 收 57.66
- 總市值 2.98亿
- 52周最高 58.00
- 市盈率 靜 --
- 換手率 0.77%
- 52周最低 34.9112
- 委 比 93.55%
- 總股本 520.03万
- 歷史最高 59.6786
- 量 比 0.79
- 振 幅 1.08%
- 歷史最低 27.2684
- 每 手 1
- 風險率 5.87%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
01-16 15:30
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
2025-12-20 04:17
Will valuations see a floor? – Morgan Stanley’s Mike Wilson
If nominal GDP and earnings growth accelerate due to higher inflation, stocks’ valuation may see a support ahead, according to Michael J. Wilson, chief U.S. equity strategist and chief investment offi...
2025-10-07 00:51
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman
Drug pricing policy clarity from the Trump administration could signal a turning point for pharmaceutical stocks (PPH), (PJP), (NYSEARCA:XPH), which have been among the worst performers this year with...
2025-10-02 02:51
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
The U.S. pharmaceutical industry is at the center of a policy maelstrom.
2025-09-30 00:06
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
2025-09-29 15:20
Trump’s 100% drug tariffs send pharma stocks lower
European and Asian pharmaceutical stocks fell Friday after President Donald Trump unveiled sweeping new tariffs, including a 100% levy on branded and patented drugs starting October 1, with exemptions...
2025-09-26 16:59
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
2025-09-08 13:49
Pullback presents buying opportunities as market will resume higher – PNC’s Yung-Yu Ma
PNC asset management chief investment strategist Yung-Yu Ma believes market pullbacks present buying opportunities despite growing concerns about weakening labor trends, as the market initially reacte...
2025-09-06 00:02
Citi’s Drew Pettit: Stocks are seeing a ‘healthy reset,’ not cause for concern
Citigroup’s director of U.S. equity strategy Drew Pettit described recent market declines as a “healthy reset” rather than a reason for alarm. In an interview with CNBC, Pettit emphasized that despite...
2025-09-03 03:38
